SCHEMBL1948836

SCHEMBL1948836

CN1C(=O)c2ccccc2C1(C)C

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PGR P06401 10/20 0.47
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CASP3 P42574 1/20 0.41
TTR P02766 1/20 0.39
CES1 P23141 1/20 0.39
MDM2 Q00987 1/20 0.39
TP53 P04637 1/20 0.38
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28243153 0.80 PGR (0.45) PGRALDH1A1MEN1KMT2ACYP1A2
SCHEMBL21663065 0.79 KDM4E (0.34) PGRALDH1A1MEN1KMT2ATTR
SCHEMBL28249000 0.78 PGR (0.46) PGRALDH1A1MEN1KMT2ACYP1A2
SCHEMBL13136409 0.77 MDM2 (0.44) PGRALDH1A1MEN1KMT2ACYP1A2
SCHEMBL23707030 0.76 PGR (0.45) PGRALDH1A1MEN1KMT2ACYP1A2
SCHEMBL30372076 0.76 HRH3 (0.51) PGRALDH1A1MEN1KMT2ACASP3
SCHEMBL30056810 0.76 MDM2 (0.57) PGRALDH1A1MEN1KMT2ACYP1A2
SCHEMBL26327450 0.75 KMT2A (0.42) PGRALDH1A1MEN1KMT2ACYP1A2
SCHEMBL12549140 0.75 CA1 (0.39) PGRALDH1A1MEN1KMT2AMDM2
SCHEMBL20672234 0.75 CA1 (0.39) MEN1KMT2AMDM2CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022253252-A1 HETEROCYCLIC COMPOUNDS USEFUL AS HPK1 INHIBITORS SILEXON BIOTECH CO., LTD. (CN) 2022-12-08 WO claimed
WO-2023220541-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES COMPOUNDS AS HPK1 INHIBITORS MERCK PATENT GMBH (DE) 2023-11-16 WO disclosed
US-20230350294-A1 Negative Photosensitive Resin Composition, Patterning Process, Interlayer Insulating Film, Surface Protection Film, And Electronic Component SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-02 US disclosed
US-20230350294-A1 Negative Photosensitive Resin Composition, Patterning Process, Interlayer Insulating Film, Surface Protection Film, And Electronic Component SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-02 US disclosed
US-11768434-B2 Polymer having a structure of polyamide, polyamide-imide, or polyimide, photosensitive resin composition, patterning process, photosensitive dry film, and protective film for electric and electronic parts SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-26 US disclosed
US-11768434-B2 Polymer having a structure of polyamide, polyamide-imide, or polyimide, photosensitive resin composition, patterning process, photosensitive dry film, and protective film for electric and electronic parts SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-26 US disclosed
US-20230183231-A1 MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS Valo Health, LLC 2023-06-15 US disclosed
WO-2022253252-A1 HETEROCYCLIC COMPOUNDS USEFUL AS HPK1 INHIBITORS SILEXON BIOTECH CO., LTD. (CN) 2022-12-08 WO disclosed
WO-2022222951-A1 AROMATIC CONDENSED RING DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 浙江海正药业股份有限公司 2022-10-27 WO disclosed
CN-114516856-A Dihydroisoquinolinone and isoindolinone derivatives and uses thereof 中国科学院合肥物质科学研究院 2022-05-20 CN disclosed
US-8106135-B2 Polyethersulfone compositions with high heat and good impact resistance SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2012-01-31 US disclosed
US-20110135601-A1 BICYCLOANILINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. 2011-06-09 US disclosed
US-20110135601-A1 BICYCLOANILINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. 2011-06-09 US disclosed
US-20110135601-A1 BICYCLOANILINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. 2011-06-09 US disclosed
EP-2168966-A1 BICYCLOANILINE DERIVATIVE Banyu Pharmaceutical Co., Ltd. (JP) 2010-03-31 EP disclosed
EP-2168966-A1 BICYCLOANILINE DERIVATIVE Banyu Pharmaceutical Co., Ltd. (JP) 2010-03-31 EP disclosed
US-20090182079-A1 Carbon Black Surface-Modified with Benzene Compound and Carbon Black Dispersion Composition for Black Matrix Using the Same CHEIL INDUSTRIES INC. (KR) 2009-07-16 US disclosed
US-20090182079-A1 Carbon Black Surface-Modified with Benzene Compound and Carbon Black Dispersion Composition for Black Matrix Using the Same CHEIL INDUSTRIES INC. (KR) 2009-07-16 US disclosed
US-20070049724-A1 POLYETHERSULFONE COMPOSITIONS WITH HIGH HEAT AND GOOD IMPACT RESISTANCE GENERAL ELECTRIC COMPANY (US) 2007-03-01 US disclosed
US-20070031514-A1 Use of isoindolinone derivatives as insecticides BAYER CROPSCIENCE AG (DE) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070031514-A1 Use of isoindolinone derivatives as insecticides DDT, CYP1A2, CYP1A1 PGR 4598/4885ALDH1A1 47/4885MEN1 2430/4885
US-20110135601-A1 BICYCLOANILINE DERIVATIVE WEE1, WEE2, CCNK PGR 2827/4885ALDH1A1 1894/4885MEN1 606/4885
US-20230183231-A1 MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS GPR119, GPR180, GPR65 PGR 935/4885ALDH1A1 2968/4885MEN1 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.